(1)
Aguilar, C.; Rodríguez-Delfín, L. Effects of Spironolactone Administration on the Podocytes Loss and Progression of Experimental Diabetic Nephropathy. Rev Peru Med Exp Salud Publica 2014, 29 (4). https://doi.org/10.17843/rpmesp.2012.294.393.